# Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

> **NCT01520350** · PHASE3 · TERMINATED · sponsor: **Serge Beaulieu** · enrollment: 2 (actual)

## Conditions studied

- Bipolar Disorder
- Depressive Episode

## Interventions

- **DRUG:** Low dose Adjunctive Aripiprazole
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01520350
- **Lead sponsor:** Serge Beaulieu
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** recruitment issues
- **Last updated:** 2014-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520350, "Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01520350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*